Control of Leishmania major in the absence of Tyk2 kinase

European Journal of Immunology

Volumn 34, Issue 2, 2004, Pages 519-529

  Schleicher, Ulrike ^a,d   Mattner, Jochen ^a,f   Blos, Martin ^a   Schindler, Heike ^a,e   Röllinghoff, Martin ^a   Karaghiosoff, Marina ^b   Müller, Mathias ^b   Werner Felmayer, Gabriele ^c   Bogdan, Christian ^a,d  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^c UNIVERSITY OF INNSBRUCK   (Austria)

^d UNIVERSITY OF FREIBURG   (Germany)

^e ROCHE DIAGNOSTICS GMBH   (Germany)

^f UNIVERSITY OF CHICAGO   (United States)

Author keywords

IL 12; Leishmania; NK cells; Tyk2

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; JANUS KINASE; STAT1 PROTEIN; STAT4 PROTEIN; DNA BINDING PROTEIN; GAMMA INTERFERON ACTIVATION FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON STIMULATED GENE FACTOR 3; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, MOUSE; PROTEIN; PROTEIN KINASE TYK2; PROTEIN TYROSINE KINASE; RNA; STAT4 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; TYK2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DISEASE MODEL; DISEASE SEVERITY; HEALING; IMMUNE RESPONSE; IMMUNITY; INFECTION CONTROL; LEISHMANIA MAJOR; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SKIN DEFECT; SKIN LEISHMANIASIS; SKIN ULCER; T LYMPHOCYTE; TH1 CELL; ANIMAL; C57BL MOUSE; CD4+ T LYMPHOCYTE; CHEMISTRY; ENZYMOLOGY; FLOW CYTOMETRY; GENETICS; HOST PARASITE INTERACTION; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PARASITOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; DNA-BINDING PROTEINS; FLOW CYTOMETRY; HOST-PARASITE RELATIONS; INTERFERON TYPE II; INTERFERON-STIMULATED GENE FACTOR 3; INTERLEUKIN-12; KILLER CELLS, NATURAL; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROTEIN-TYROSINE KINASES; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SIGNAL TRANSDUCTION; STAT4 TRANSCRIPTION FACTOR; TH1 CELLS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TYK2 KINASE;

EID: 1642269148     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200324465     Document Type: Article

References (37)

1. Bogdan, C., Röllinghoff, M. and Diefenbach, A., Nitric oxide in leishmaniasis: from antimicrobial activity to immunoregulation. In Fang, F. (Ed.), Nitric oxide and infection, Kluwer Academic/Plenum Publishers, New York 1999, p. 361-377.
2. Solbach, W. and Laskay, T., The host response to Leishmania infection. Adv. Immunol. 2000. 74: 275-317.
3. Sacks, D. L. and Noben-Trauth, N., The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2002. 2: 845-858.
4. Lohoff, M., Duncan, G. S., Ferrick, D., Mittrücker, H.-W., Bischof, S., Prechtl, S., Röllinghoff, M., Schmitt, E., Pahl, A. and Mak, T. W., Deficiency in the transcription factor interferon regulatory factor (IRF)-2 leads to severely compromised development of natural killer and T helper type 1 cells. J. Exp. Med. 2000. 192: 325-335.
5. Szabo, S. J., Sullivan, B. M., Stemmann, C., Satoskar, A. R., Sleckman, B. P. and Glimcher, L. H., Distinct effects of T-bet in Th1 lineage commitment and IFN-γ production in CD4 and CD8 T cells. Science 2002. 295: 338-242.
6. Blos, M., Schleicher, U., Rocha, F. J., Meissner, U., Röllinghoff, M. and Bogdan, C., Organ-specific and stage-dependent control of Leishmania major infection by inducible nitric oxide synthase and phagocyte NADPH oxidase. Eur. J. Immunol. 2003. 33: 1224-1234.
7. Scharton-Kersten, T., Afonso, L. C. C., Wysocka, M., Trinchieri, G. and Scott, P., IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 1995. 154: 5320-5330.
8. Carter, L. L. and Murphy, K. M., Lineage-specific requirement for signal transducer and activator of transcription (Stat)4 in interferon-γ production from CD4+ versus CD8+ T cells. J. Exp. Med. 1999. 189: 1355-1360.
9. Trinchieri, G., Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 2003. 3: 133-146.
10. Stobie, L., Gurunathan, S., Prussin, C., Sacks, D. L., Glaichenhaus, N., Wu, C.-Y. and Seder, R. A., The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge. Proc. Natl. Acad. Sci. USA 2000. 15: 8427-8432.
11. Park, A. Y., Hondowicz, B., Kopf, M. and Scott, P., The role of IL-12 in maintaining resistance to Leishmania major. J. Immunol. 2002. 168: 5771-5777.
12. Taylor, A. P. and Murray, H. W., Intracellular antimicrobial activity in the absence of interferon-γ: effect of interleukin-12 in experimental visceral leishmaniasis in interferon-γ gene-disrupted mice. J. Exp. Med. 1997. 185: 1231-1239.
13. Mattner, F., Di Padova, K. and Alber, G., Interleukin-12 is indispensable for protective immunity against Leishmania major. Infect. Immun. 1997. 65: 4378-4383.
14. Belkaid, Y., Mendez, S., Lira, R., Kadambi, N., Milon, G. and Sacks, D. L., A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity. J. Immunol. 2000. 165: 969-977.
15. Bacon, C. M., McVicar, D. W., Ortaldo, J. R., Rees, R. C., O'Shea, J. J. and Johnston, J. A., Interleukin-12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12. J. Exp. Med. 1995. 181: 399-404.
16. Jacobson, N. G., Szabo, S. J., Weber-Nordt, R. M., Zhong, Z., Schreiber, R. D., Darnell, J. E. and Murphy, K. M., Interleukin-12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat) 3 and Stat4. J. Exp. Med. 1995. 181: 1755-1762.
17. Karaghiosoff, M., Neubauer, H., Lassnig, C., Kovarik, P., Schindler, H., Pircher, H.-P., McCoy, B., Bogdan, C., Decker, T., Brem, G., Pfeffer, K. and Müller, M., Partial impairment of cytokine responses in tyk2-deficient mice. Immunity 2000. 13: 549-560.
18. Shimoda, K., Kato, K., Aoki, K., Matsuda, T., Miyamoto, A., Shibamori, M., Yamashita, M., Numata, A., Takase, K., Kobayashi, S., Shibata, S., Asano, Y., Gondo, H., Sekiguchi, K., Nakayama, K., Nakayama, T., Okamura, T., Okamura, S., Niho, Y. and Nakayama, K.-i., Tyk2 plays a restricted role in IFNα signaling, although it is required for IL-12-mediated T cell function. Immunity 2000. 13: 561-571.
19. Karaghiosoff, M., Steinborn, R., Kovarik, P., Kriegshäuser, G., Baccarini, M., Donabauer, B., Reichart, U., Kolbe, T., Bogdan, C., Leanderson, T., Levy, D., Decker, T. and Müller, M., Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock. Nat. Immunol. 2003. 4: 471-477.
20. Stamm, L. M., Satoskar, A. A., Ghosh, S. K., David, J. R. and Satoskar, A. R., STAT4-mediated IL-12 signaling pathway is critical for the development of protective immunity in cutaneous leishmaniasis. Eur. J. Immunol. 1999. 29: 2524-2529.
21. Diefenbach, A., Schindler, H., Röllinghoff, M., Yokoyama, W. and Bogdan, C., Requirement for type 2 NO-synthase for IL-12 responsiveness in innate immunity. Science 1999. 284: 951-955.
22. Gracie, J. A., Robertson, S. E. and McInnes, I. B., Interleukin-18. J. Leukocyt. Biol. 2003. 73: 213-224.
23. Diefenbach, A., Schindler, H., Donhauser, N., Lorenz, E., Laskay, T., MacMicking, J., Röllinghoff, M., Gresser, I. and Bogdan, C., Type 1 interferon (IFN-α/β) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 1998. 8: 77-87.
24. Mattner, J., Schindler, H., Diefenbach, A., Röllinghoff, M., Gresser, I. and Bogdan, C., Regulation of type 2 NO synthase by type I interferons in macrophages infected with Leishmania major. Eur. J. Immunol. 2000. 30: 2257-2267.
25. Bogdan, C., The function of type I interferons in antimicrobial immunity. Curr. Opin. Immunol. 2000. 12: 419-424.
26. Toshchakov, V., Jones, B. W., Perera, P.-Y., Thomas, K., Cody, M. J., Zhang, S., Williams, B. R. G., Major, J., Hamilton, T. A., Fenton, M. J. and Vogel, S. N., TLR4, but not TLR2, mediates IFN-β-induced STAT1αβ-dependent gene expression in macrophages. Nat. Immunol. 2002. 3: 392-398.
27. Shimoda, K., Tsutsui, H., Aoki, K., Kato, K., Matsuda, T., Numata, A., Takase, K., Yamamoto, T., Nukina, H., Hoshino, T., Asano, Y., Gondo, H., Okamura, T., Okamura, S., Nakayama, K.-I., Nakanishi, K., Niho, Y. and Harada, M., Partial impairment of interleukin-12 and IL-18 signaling in Tyk2-deficient mice. Blood 2002. 99: 2094-2099.
28. Laskay, T., Röllinghoff, M. and Solbach, W., Natural killer cells participate in the early defense against Leishmania major infection in mice. Eur. J. Immunol. 1993. 23: 2237-2241.
29. Scharton, T. M. and Scott, P., Natural killer cells are a source of IFN-γ that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 1993. 178: 567-578.
30. Satoskar, A. R., Stamm, L. M., Zhang, X., Satoskar, A. A., Okano, M., Terhorst, C., David, J. R. and Wang, B., Mice lacking NK cells develop an efficient Th1 response and control cutaneous Leishmania major infection. J. Immunol. 1999. 162: 6747-6754.
31. Wang, Z.-E., Reiner, S. L., Hatam, F., Heinzel, F. R, Bouvier, J., Turck, C. W. and Locksley, R. M., Targeted activation of CD8 cells and infection of β2-microglobulin-deficient mice fail to confirm a primary protective role for CD8 cells in experimental leishmaniasis. J. Immunol. 1993. 151: 2077-2086.
32. Huber, M., Timms, E., Mak, T. W., Röllinghoff, M. and Lohoff, M., Effective and long-lasting immunity against the parasite Leishmania major in CD8-deficient mice. Infect. Immun. 1998. 66: 3968-3970.
33. Titus, R. G., Milon, G., Marchal, G., Vassalli, P., Cerottini, J.-C. and Louis, J. A., Involvement of specific Lyt-2+ T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis. Eur. J. Immunol. 1987. 17: 1429-1433.
34. Belkaid, Y., von Stebut, E., Mendez, S., Lira, R., Caler, E., Bertholet, S., Udey, M. C. and Sacks, D. L., CD8+ T cells are required for primary immunity in C57BL/6 mice following lowdose, intradermal challenge with Leishmania major. J. Immunol. 2002. 168: 3992-4000.
35. Wilhelm, P., Ritter, U., Labbow, S., Donhauser, N., Röllinghoff, M., Bogdan, C. and Körner, H., Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking tumor necrosis factor. J. Immunol. 2001. 166: 4012-4019.
36. Stenger, S., Donhauser, N., Thüring, H., Röllinghoff, M. and Bogdan, C., Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J. Exp. Med. 1996. 183: 1501-1514.
37. Schindler, H., Lutz, M. B., Röllinghoff, M. and Bogdan, C., The production of IFN-γ by IL-12/IL-18-activated macrophages requires STAT4 signaling and is inhibited by IL-4. J. Immunol. 2001. 166: 3075-3082.